Measurement of free radical damage is an important test which can help unveil potentially severe health problems including cardiovascular diseases.

As a number of medical studies have shown, the excess of free radicals in a human body lead to cells damage that has been linked to chronic conditions such as arthritis, cancer, diabetes, Alzheimer’s disease, strokes and rapid aging.

Revelar technology is the first non-invasive device that measures aldehydes, known indicators of free radical damage. It is based on a breath testing system designed to help healthcare professionals test for a level of oxidative stress in the body.

Oxidative Stress Test & The Revelar Score

The increasing interest in free radicals, in both the lay and scientific communities, brought in a need for a tool to evaluate the link between free radicals, oxidative stress, and disease.

The Revelar device is designed to measure the balance between the production of free radicals and the body’s ability to neutralise those free radicals at any given point in time.

The test provides a score whcih is to help doctors determine the amount of oxidative stress in patients and advise them on lifestyle that can improve their health. Additionally, it can be used to determine the type and amount of nutritional supplementation as well as an individual takes to decrease the risk of health deterioration or disease.

The Measurement of Aldehydes

Revelar test gives an aldehyde score based on testing aldehyde levels. Aldehydes are the byproducts of oxidative stress therefore their measurement has proven to be an effective biomarker of excess free radicals in a human body. The Revelar test is based on research relating to aldehyde measurement in exhaled breath condensate. Many studies have shown a correlation between breath aldehydes and disease states.